|
FAM135A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.55470000393765E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.73740000018053E-07 |
| Normal-vs-Stage2 |
1.984180E-02 |
| Normal-vs-Stage3 |
1.557590E-01 |
| Normal-vs-Stage4 |
9.499700E-02 |
| Stage1-vs-Stage2 |
4.620600E-01 |
| Stage1-vs-Stage3 |
8.523900E-03 |
| Stage1-vs-Stage4 |
9.479000E-01 |
| Stage2-vs-Stage3 |
7.426100E-02 |
| Stage2-vs-Stage4 |
5.900000E-01 |
| Stage3-vs-Stage4 |
2.713000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.33409999997425E-06 |
| Normal-vs-AfricanAmerican |
1.76116999999198E-05 |
| Normal-vs-Asian |
1.865560E-01 |
| Caucasian-vs-AfricanAmerican |
7.558100E-02 |
| Caucasian-vs-Asian |
6.057200E-01 |
| AfricanAmerican-vs-Asian |
3.181200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.3281000016695E-08 |
| Normal-vs-Female |
3.962900E-03 |
| Male-vs-Female |
1.119400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.355900E-03 |
| Normal-vs-Extreme_Weight |
7.74650000000543E-05 |
| Normal-vs-Obese |
4.811000E-04 |
| Normal-vs-Extreme_Obese |
1.073560E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.233800E-01 |
| Normal_Weight-vs-Obese |
8.091000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.370600E-01 |
| Extreme_Weight-vs-Obese |
8.402400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.966200E-01 |
| Obese-vs-Extreme_Obese |
6.215600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.712400E-02 |
| Normal-vs-Age(41-60Yrs) |
2.17250000211777E-08 |
| Normal-vs-Age(61-80Yrs) |
3.9083999999967E-05 |
| Normal-vs-Age(81-100Yrs) |
8.516600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.587800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.454400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.094180E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.461780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.058400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.258830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.10929060276521E-12 |
| Normal-VS-Type2 PRCC |
4.554600E-01 |
| Normal-VS-KIRP CIMP |
2.781200E-01 |
| Normal-VS-Unclassified PRCC |
1.632500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.93539999768933E-08 |
| Type1 PRCC-VS-KIRP CIMP |
3.396000E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.604710E-03 |
| Type2 PRCC-VS-KIRP CIMP |
6.701200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.228750E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.261600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.312110E-02 |
| Normal-vs-N1 |
6.828300E-02 |
| Normal-vs-N2 |
5.970600E-01 |
| N0-vs-N1 |
6.841200E-01 |
| N0-vs-N2 |
2.398400E-01 |
| N1-vs-N2 |
3.115400E-01 |
|
|
